---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-009157"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2026-01-29T23:59:59+00:00"
generated_at: "2026-05-16T06:33:59.110514+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics enters $6M equity line of credit with Tumim Stone Capital

## Summary
- Company may sell up to $6M of common stock at 95-97% of VWAP discount.
- Commitment fee of $45,000 paid to investor upon execution.
- Shares subject to Exchange Cap (19.99% of outstanding) unless stockholder waiver obtained.
- Company must seek stockholder approval at next annual meeting to waive Exchange Cap.
- Investor cannot own more than 4.99% (or 9.99% at its election) of outstanding shares.

## SEC filing metadata
- accession: 0001213900-26-009157
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2026-01-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/0001213900-26-009157-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/ea0274173-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-009157
- JSON: https://secwatch.observer/filing/0001213900-26-009157.json
- Plain text: https://secwatch.observer/filing/0001213900-26-009157.txt

## Key facts
- Material Agreements
  Allarity Therapeutics, Inc. entered into Common Stock Purchase Agreement with Tumim Stone Capital LLC (effective 2026-01-28).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Tumim Stone Capital LLC
  - Effective: 2026-01-28
  source text: On January 28, 2026, Allarity Therapeutics, Inc. (the “ Company ”) entered into a Common Stock Purchase Agreement (the “ Purchase Agreement ”) with Tumim Stone Capital LLC, a Delaware limited liability company (the “ Investor ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/0001213900-26-009157-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.